A detailed history of Pnc Financial Services Group, Inc. transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 470 shares of SMMT stock, worth $8,774. This represents 0.0% of its overall portfolio holdings.

Number of Shares
470
Previous 45 944.44%
Holding current value
$8,774
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$6.89 - $31.93 $2,928 - $13,570
425 Added 944.44%
470 $10,000
Q2 2024

Aug 09, 2024

BUY
$2.39 - $10.92 $107 - $491
45 New
45 $0
Q4 2021

Feb 11, 2022

SELL
$2.45 - $5.64 $4,900 - $11,280
-2,000 Closed
0 $0
Q3 2021

Nov 05, 2021

BUY
$4.83 - $8.27 $4,830 - $8,270
1,000 Added 100.0%
2,000 $10,000
Q2 2021

Aug 06, 2021

BUY
$5.15 - $8.46 $5,150 - $8,460
1,000 New
1,000 $7,000

Others Institutions Holding SMMT

About Summit Therapeutics Inc.


  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $3.76B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.